Henry Schein shares up on strategic investment from KKR, management appointments, share buyback, and preliminary results.

Straumann, Dentsply Sirona, Zimmer Biomet, Henry Schein, Envista, Dentium, and Osstem Implant are some of the key vendors and these large multinational corporations dominate the market ...

Of late, the company is witnessing consistent demand for these implant systems and endodontic products and integrated software and services solutions. Further, Henry Schein is organically gaining ...

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Dental supply company Henry Schein Inc (NASDAQ ... and in global sales of implants and biomaterials largely driven by acquisitions, and were negatively impacted by higher-than-usual acquisition ...

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...

Henry Schein (HSIC) stock in focus as KKR (KKR) builds stake and the company posts its preliminary Q4 2024 financials. Read ...

This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...